Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Long Interspersed Nucleotide Elements | 13 | 2023 | 330 | 3.600 |
Why?
|
RNA-Directed DNA Polymerase | 4 | 2024 | 225 | 1.850 |
Why?
|
Ribonucleoproteins | 4 | 2018 | 372 | 1.370 |
Why?
|
Acyltransferases | 4 | 2015 | 305 | 1.250 |
Why?
|
Endonucleases | 2 | 2023 | 371 | 1.220 |
Why?
|
Ghrelin | 4 | 2015 | 252 | 0.960 |
Why?
|
Mutagenesis | 4 | 2024 | 1232 | 0.940 |
Why?
|
Open Reading Frames | 4 | 2016 | 815 | 0.920 |
Why?
|
Acute Lung Injury | 2 | 2018 | 367 | 0.920 |
Why?
|
Reverse Transcription | 1 | 2023 | 47 | 0.910 |
Why?
|
Enzyme Assays | 2 | 2015 | 104 | 0.840 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2024 | 489 | 0.730 |
Why?
|
DNA | 5 | 2024 | 7212 | 0.710 |
Why?
|
Chromosome Segregation | 1 | 2020 | 235 | 0.640 |
Why?
|
Granuloma, Plasma Cell | 1 | 2019 | 80 | 0.610 |
Why?
|
DNA Repair | 3 | 2024 | 2045 | 0.600 |
Why?
|
DNA Replication | 4 | 2024 | 1418 | 0.570 |
Why?
|
Macromolecular Substances | 2 | 2023 | 1434 | 0.540 |
Why?
|
Evolution, Molecular | 4 | 2024 | 1886 | 0.520 |
Why?
|
Carcinoma | 3 | 2023 | 2330 | 0.500 |
Why?
|
Pulmonary Alveoli | 1 | 2018 | 652 | 0.490 |
Why?
|
Autoantibodies | 3 | 2021 | 2116 | 0.480 |
Why?
|
Biotin | 1 | 2015 | 254 | 0.460 |
Why?
|
DNA Damage | 1 | 2024 | 2446 | 0.460 |
Why?
|
RNA | 4 | 2023 | 2726 | 0.460 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 550 | 0.450 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 505 | 0.450 |
Why?
|
Genome | 3 | 2020 | 1740 | 0.450 |
Why?
|
RNA-Binding Protein EWS | 3 | 2019 | 210 | 0.440 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2021 | 2155 | 0.430 |
Why?
|
Multiprotein Complexes | 2 | 2016 | 1118 | 0.410 |
Why?
|
Mutation | 12 | 2024 | 30052 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2021 | 3639 | 0.400 |
Why?
|
Carcinoma, Pancreatic Ductal | 6 | 2021 | 1727 | 0.400 |
Why?
|
Lung Transplantation | 2 | 2018 | 1310 | 0.380 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2469 | 0.380 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6935 | 0.370 |
Why?
|
Chromatography, Affinity | 3 | 2018 | 532 | 0.370 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3877 | 0.340 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2018 | 1462 | 0.340 |
Why?
|
Pancreatic Neoplasms | 7 | 2021 | 5368 | 0.330 |
Why?
|
Retroelements | 3 | 2023 | 163 | 0.330 |
Why?
|
Regeneration | 1 | 2018 | 1511 | 0.320 |
Why?
|
Sarcoma | 4 | 2021 | 1801 | 0.310 |
Why?
|
Barrett Esophagus | 2 | 2022 | 492 | 0.290 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3712 | 0.280 |
Why?
|
Leucovorin | 5 | 2021 | 643 | 0.280 |
Why?
|
Genome, Human | 3 | 2015 | 4425 | 0.280 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4876 | 0.270 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 269 | 0.270 |
Why?
|
Liver Neoplasms | 5 | 2021 | 4320 | 0.270 |
Why?
|
Immunohistochemistry | 4 | 2022 | 11076 | 0.250 |
Why?
|
Mass Spectrometry | 4 | 2018 | 2192 | 0.250 |
Why?
|
Neoplasms | 8 | 2024 | 22170 | 0.250 |
Why?
|
Proteome | 2 | 2020 | 1862 | 0.240 |
Why?
|
Gene Expression | 3 | 2019 | 7581 | 0.240 |
Why?
|
Neoadjuvant Therapy | 6 | 2021 | 2827 | 0.240 |
Why?
|
Alkylation | 1 | 2024 | 84 | 0.240 |
Why?
|
SOXF Transcription Factors | 1 | 2024 | 31 | 0.230 |
Why?
|
Fluorouracil | 5 | 2021 | 1641 | 0.230 |
Why?
|
HeLa Cells | 5 | 2020 | 3093 | 0.230 |
Why?
|
DNA Adducts | 1 | 2024 | 94 | 0.230 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 56 | 0.220 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2024 | 200 | 0.210 |
Why?
|
Humans | 71 | 2024 | 761504 | 0.210 |
Why?
|
Interferons | 2 | 2023 | 706 | 0.210 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2024 | 367 | 0.200 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2022 | 106 | 0.190 |
Why?
|
Cell Line | 4 | 2024 | 15601 | 0.190 |
Why?
|
Esophageal Neoplasms | 2 | 2022 | 1654 | 0.180 |
Why?
|
Homozygote | 6 | 2020 | 1776 | 0.180 |
Why?
|
Germ Cells | 2 | 2022 | 634 | 0.180 |
Why?
|
Sister Chromatid Exchange | 1 | 2020 | 60 | 0.180 |
Why?
|
Immune Evasion | 1 | 2024 | 363 | 0.180 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2020 | 450 | 0.180 |
Why?
|
raf Kinases | 1 | 2020 | 118 | 0.170 |
Why?
|
HEK293 Cells | 6 | 2024 | 4278 | 0.170 |
Why?
|
Mucociliary Clearance | 1 | 2020 | 80 | 0.170 |
Why?
|
Cryoelectron Microscopy | 1 | 2023 | 650 | 0.170 |
Why?
|
Adenocarcinoma | 4 | 2021 | 6346 | 0.170 |
Why?
|
Neoplasm Invasiveness | 4 | 2022 | 3595 | 0.170 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 428 | 0.170 |
Why?
|
Gene Fusion | 2 | 2019 | 356 | 0.170 |
Why?
|
Transcription, Genetic | 3 | 2024 | 7594 | 0.170 |
Why?
|
Genetic Variation | 2 | 2020 | 6567 | 0.160 |
Why?
|
Ultraviolet Rays | 1 | 2024 | 1080 | 0.160 |
Why?
|
Common Variable Immunodeficiency | 1 | 2020 | 101 | 0.160 |
Why?
|
Crystallography, X-Ray | 1 | 2023 | 1990 | 0.160 |
Why?
|
Lysosomes | 1 | 2024 | 924 | 0.160 |
Why?
|
Mice | 16 | 2024 | 81525 | 0.160 |
Why?
|
RNA-Binding Protein FUS | 1 | 2019 | 76 | 0.160 |
Why?
|
Alleles | 4 | 2020 | 6863 | 0.160 |
Why?
|
Animals | 23 | 2024 | 168459 | 0.160 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.160 |
Why?
|
Gallbladder Neoplasms | 1 | 2020 | 189 | 0.150 |
Why?
|
Heterozygote | 3 | 2014 | 2787 | 0.150 |
Why?
|
Organometallic Compounds | 2 | 2020 | 647 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1718 | 0.150 |
Why?
|
Hepatitis | 1 | 2020 | 228 | 0.150 |
Why?
|
Selection, Genetic | 2 | 2020 | 868 | 0.150 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2529 | 0.150 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 420 | 0.150 |
Why?
|
Hypertension, Portal | 1 | 2020 | 226 | 0.150 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2018 | 88 | 0.150 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1159 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11742 | 0.140 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1125 | 0.140 |
Why?
|
Autopsy | 1 | 2021 | 1008 | 0.140 |
Why?
|
Colonic Neoplasms | 2 | 2019 | 2538 | 0.140 |
Why?
|
Structure-Activity Relationship | 2 | 2013 | 3076 | 0.140 |
Why?
|
NFATC Transcription Factors | 1 | 2019 | 389 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
Time | 1 | 2018 | 546 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 504 | 0.130 |
Why?
|
Cysts | 1 | 2021 | 681 | 0.130 |
Why?
|
Lymphatic Metastasis | 2 | 2020 | 2915 | 0.130 |
Why?
|
Baculoviridae | 1 | 2015 | 115 | 0.120 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 370 | 0.120 |
Why?
|
DNA Polymerase I | 1 | 2015 | 43 | 0.120 |
Why?
|
Proteins | 2 | 2023 | 6032 | 0.120 |
Why?
|
Acylation | 2 | 2012 | 96 | 0.120 |
Why?
|
ras Proteins | 1 | 2020 | 1054 | 0.120 |
Why?
|
DNA Polymerase III | 1 | 2015 | 51 | 0.120 |
Why?
|
Amino Acid Sequence | 3 | 2018 | 13446 | 0.120 |
Why?
|
Protein Binding | 3 | 2016 | 9351 | 0.120 |
Why?
|
Phenelzine | 1 | 2014 | 28 | 0.120 |
Why?
|
Male | 31 | 2021 | 360804 | 0.120 |
Why?
|
Conserved Sequence | 2 | 2015 | 1163 | 0.120 |
Why?
|
Anophthalmos | 1 | 2014 | 23 | 0.120 |
Why?
|
Female | 30 | 2023 | 392644 | 0.110 |
Why?
|
Camptothecin | 1 | 2017 | 591 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1157 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9280 | 0.110 |
Why?
|
Adult | 21 | 2021 | 221177 | 0.110 |
Why?
|
Pancreas | 1 | 2020 | 1691 | 0.110 |
Why?
|
Deoxyribonuclease I | 1 | 2014 | 224 | 0.110 |
Why?
|
Adenoma | 1 | 2024 | 2160 | 0.110 |
Why?
|
Signal Transduction | 5 | 2024 | 23445 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1250 | 0.110 |
Why?
|
Blood Vessels | 1 | 2019 | 1113 | 0.110 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2012 | 15 | 0.110 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2013 | 283 | 0.100 |
Why?
|
RNA Helicases | 1 | 2013 | 144 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2021 | 1390 | 0.100 |
Why?
|
Atlases as Topic | 1 | 2014 | 248 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4111 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 641 | 0.100 |
Why?
|
Codon, Nonsense | 1 | 2014 | 285 | 0.100 |
Why?
|
Receptors, Ghrelin | 1 | 2012 | 20 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1230 | 0.100 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 9606 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1298 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2612 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 774 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2020 | 3466 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2014 | 522 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2023 | 3065 | 0.100 |
Why?
|
Eye Abnormalities | 1 | 2014 | 242 | 0.100 |
Why?
|
Chickens | 1 | 2013 | 859 | 0.090 |
Why?
|
Histone Demethylases | 1 | 2014 | 320 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2024 | 3548 | 0.090 |
Why?
|
Neutrophils | 2 | 2021 | 3767 | 0.090 |
Why?
|
Eye Proteins | 1 | 2014 | 633 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2496 | 0.090 |
Why?
|
Neoplasm Staging | 3 | 2020 | 11121 | 0.090 |
Why?
|
Protein Structure, Secondary | 1 | 2013 | 1229 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3734 | 0.090 |
Why?
|
Middle Aged | 20 | 2021 | 220895 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2019 | 2986 | 0.090 |
Why?
|
Intelligence | 1 | 2015 | 924 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3683 | 0.080 |
Why?
|
Aged | 17 | 2021 | 169289 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1935 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2022 | 2917 | 0.080 |
Why?
|
Sequence Alignment | 1 | 2013 | 2180 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2898 | 0.080 |
Why?
|
Prognosis | 8 | 2022 | 29625 | 0.080 |
Why?
|
Peptides | 2 | 2012 | 4358 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2020 | 6814 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3617 | 0.080 |
Why?
|
Chromatin | 2 | 2024 | 2960 | 0.080 |
Why?
|
Dogs | 1 | 2013 | 3839 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.080 |
Why?
|
Membrane Proteins | 3 | 2015 | 7856 | 0.080 |
Why?
|
Exons | 1 | 2013 | 2391 | 0.070 |
Why?
|
Genetic Heterogeneity | 2 | 2021 | 732 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2017 | 1157 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2015 | 2116 | 0.070 |
Why?
|
Models, Molecular | 2 | 2015 | 5439 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2020 | 16981 | 0.070 |
Why?
|
Down-Regulation | 1 | 2013 | 2919 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2020 | 1749 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5796 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6055 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2012 | 3597 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2015 | 3395 | 0.060 |
Why?
|
Hepatectomy | 2 | 2020 | 557 | 0.060 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1616 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4575 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2014 | 2448 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18252 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12690 | 0.060 |
Why?
|
Liver | 1 | 2020 | 7529 | 0.060 |
Why?
|
Child | 7 | 2021 | 80153 | 0.060 |
Why?
|
Rats, Inbred BN | 1 | 2004 | 231 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 6403 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2872 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2856 | 0.060 |
Why?
|
Saccharomyces cerevisiae | 1 | 2015 | 2688 | 0.060 |
Why?
|
Macrophages | 1 | 2019 | 5769 | 0.060 |
Why?
|
Transcription Initiation Site | 2 | 2014 | 188 | 0.050 |
Why?
|
Genomics | 2 | 2013 | 5821 | 0.050 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 2023 | 20 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2014 | 12795 | 0.050 |
Why?
|
Endoderm | 1 | 2024 | 160 | 0.050 |
Why?
|
Models, Biological | 2 | 2020 | 9469 | 0.050 |
Why?
|
Genotype | 2 | 2018 | 12990 | 0.050 |
Why?
|
Phenotype | 6 | 2020 | 16591 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15732 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5789 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7407 | 0.050 |
Why?
|
Agrin | 1 | 2022 | 75 | 0.050 |
Why?
|
Ribonucleotides | 1 | 2022 | 114 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3518 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3849 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2024 | 1991 | 0.050 |
Why?
|
Body Weight | 1 | 2012 | 4618 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17635 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 366 | 0.050 |
Why?
|
Transcription Factors | 3 | 2015 | 12128 | 0.040 |
Why?
|
Disease Progression | 3 | 2024 | 13506 | 0.040 |
Why?
|
Weight Gain | 1 | 2010 | 2348 | 0.040 |
Why?
|
Genes, MHC Class I | 1 | 2021 | 235 | 0.040 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2020 | 110 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2020 | 85 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 64680 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15266 | 0.040 |
Why?
|
Complement C1q | 1 | 2020 | 93 | 0.040 |
Why?
|
Turkey | 1 | 2020 | 254 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2020 | 241 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 233 | 0.040 |
Why?
|
Heterocyclic Compounds | 1 | 2020 | 246 | 0.040 |
Why?
|
Asthma | 1 | 2018 | 6234 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 396 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4346 | 0.040 |
Why?
|
Molecular Probes | 1 | 2020 | 309 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59243 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2020 | 523 | 0.040 |
Why?
|
Biopsy | 2 | 2020 | 6766 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 345 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2018 | 51 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 343 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 233 | 0.040 |
Why?
|
Germany | 1 | 2020 | 875 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 943 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4915 | 0.040 |
Why?
|
Complement C3 | 1 | 2020 | 435 | 0.040 |
Why?
|
Organoids | 1 | 2024 | 740 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 978 | 0.040 |
Why?
|
Pyroglyphidae | 1 | 2018 | 89 | 0.040 |
Why?
|
Survival Analysis | 2 | 2020 | 10090 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2020 | 456 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6990 | 0.040 |
Why?
|
Blood Glucose | 1 | 2012 | 6391 | 0.040 |
Why?
|
Viral Proteins | 1 | 2024 | 1804 | 0.040 |
Why?
|
Introns | 2 | 2014 | 981 | 0.030 |
Why?
|
Adolescent | 6 | 2021 | 88319 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2020 | 3673 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 368 | 0.030 |
Why?
|
Respiratory System | 1 | 2020 | 563 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13380 | 0.030 |
Why?
|
Pedigree | 2 | 2014 | 4542 | 0.030 |
Why?
|
Lupus Nephritis | 1 | 2020 | 316 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1596 | 0.030 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2015 | 22 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 344 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 407 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1595 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2020 | 811 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1387 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2024 | 3162 | 0.030 |
Why?
|
Scotland | 1 | 2015 | 143 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2019 | 569 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2019 | 926 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9463 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2020 | 80636 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39106 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8547 | 0.030 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2014 | 46 | 0.030 |
Why?
|
Corneal Opacity | 1 | 2014 | 47 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1720 | 0.030 |
Why?
|
Microphthalmos | 1 | 2014 | 58 | 0.030 |
Why?
|
Coloboma | 1 | 2014 | 59 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 4920 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 745 | 0.030 |
Why?
|
Monoamine Oxidase | 1 | 2014 | 181 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3305 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 41487 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1328 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2020 | 815 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10445 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2510 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2049 | 0.030 |
Why?
|
Puromycin | 1 | 2012 | 42 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1092 | 0.030 |
Why?
|
Genes, Essential | 1 | 2014 | 185 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1913 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2811 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 2002 | 1285 | 0.030 |
Why?
|
Cell Survival | 2 | 2014 | 5791 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2020 | 0.030 |
Why?
|
DNA Cleavage | 1 | 2012 | 56 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 2048 | 0.030 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2012 | 100 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22176 | 0.020 |
Why?
|
Collagen | 1 | 2020 | 2638 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3602 | 0.020 |
Why?
|
Polyadenylation | 1 | 2012 | 117 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1606 | 0.020 |
Why?
|
Kinetics | 1 | 2018 | 6374 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
RNA Stability | 1 | 2012 | 329 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4580 | 0.020 |
Why?
|
Microcephaly | 1 | 2014 | 425 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3060 | 0.020 |
Why?
|
Gene Library | 1 | 2012 | 1059 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5869 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4544 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1967 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1886 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23995 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1003 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2018 | 1171 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4511 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 18965 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3606 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6484 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1675 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9420 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3032 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8320 | 0.020 |
Why?
|
United States | 3 | 2020 | 72334 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8529 | 0.020 |
Why?
|
Adenosine | 1 | 2012 | 808 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 15936 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1178 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2707 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20570 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12441 | 0.020 |
Why?
|
Fetus | 1 | 2014 | 1863 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1967 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22169 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5035 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 3968 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14666 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 803 | 0.020 |
Why?
|
Ion Channels | 1 | 2010 | 1040 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8830 | 0.020 |
Why?
|
Drug Design | 1 | 2010 | 1048 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12725 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1745 | 0.020 |
Why?
|
Polymers | 1 | 2012 | 1617 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2012 | 2113 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7967 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 976 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58976 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9539 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1341 | 0.010 |
Why?
|
Child, Preschool | 2 | 2019 | 42230 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.010 |
Why?
|
Base Composition | 1 | 2004 | 290 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4652 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2831 | 0.010 |
Why?
|
Rats | 2 | 2014 | 23742 | 0.010 |
Why?
|
Histones | 1 | 2014 | 2580 | 0.010 |
Why?
|
Chromosomes, Mammalian | 1 | 2004 | 147 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1897 | 0.010 |
Why?
|
Centromere | 1 | 2004 | 212 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3429 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36426 | 0.010 |
Why?
|
RNA Splice Sites | 1 | 2004 | 211 | 0.010 |
Why?
|
Gene Duplication | 1 | 2004 | 314 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18395 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8181 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3448 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 17904 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15842 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8631 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11528 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21353 | 0.010 |
Why?
|
RNA, Untranslated | 1 | 2004 | 459 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2004 | 790 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2004 | 755 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4398 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20098 | 0.010 |
Why?
|
Homeostasis | 1 | 2010 | 3323 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39967 | 0.010 |
Why?
|
CpG Islands | 1 | 2004 | 1230 | 0.010 |
Why?
|
Lung | 1 | 2018 | 10000 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.010 |
Why?
|
Electrophysiology | 1 | 2002 | 1262 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2004 | 865 | 0.010 |
Why?
|
Inflammation | 1 | 2018 | 10773 | 0.010 |
Why?
|
Telomere | 1 | 2004 | 943 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6596 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11903 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14414 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2002 | 1974 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4740 | 0.010 |
Why?
|